Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer

Citations

WEB OF SCIENCE

1
Citations

SCOPUS

1

초록

Aim: The role of regional nodal irradiation (RNI) after preoperative systemic treatment (PST) with targeted therapy for HER2-positive breast cancer remains uncertain. This study aimed to investigate the impact of RNI on locoregional recurrence (LRR) and disease-free survival (DFS) outcomes after docetaxel/carboplatin/trastuzu-mab/pertuzumab (TCHP) for PST.Methods: We retrospectively analyzed 255 patients who were treated with six cycles of TCHP between 2016 and 2019. The patients were divided into four groups based on clinical nodal involvement: group A, with no nodal disease; group B, with axillary lymph node (AXL) level I; group C, with AXL level I with II/III; and group D, with supraclavicular or internal mammary nodes.Results: The RNI group had more advanced nodal disease (C/D) than the no RNI group (56.9 % vs. 6.8 %). With a median follow-up of 51.3 months, there were two (0.8 %), three (1.2 %), and 15 (5.9 %) local, regional, and distant metastases, respectively. LRR did not differ significantly according to the RNI (2.6 % vs. 1.0 %, p = 0.651). Group D had the most frequent distant metastases (17.5 %; p = 0.005). The 4-year DFS rate was 92.7 %, and DFS did not improve significantly after RNI (p = 0.074). When stratified by clinical nodal groups and pathological axillary response, RNI had no effect on LRR/DFS outcomes.Conclusion: With a rare incidence of LRR, RNI did not significantly affect LRR or DFS in patients with HER2-positive breast cancer after with PST-TCHP. However, intensive systemic treatment is required for advanced diseases (C/D). Selective de-intensified RNI and intensified systemic treatment should be investigated in future studies.

키워드

Radiation therapy; HER2-positive breast cancer; Neoadjuvant; Anti-HER2 targeted therapy; Primary systemic therapy; PATHOLOGICAL COMPLETE RESPONSE; INTERNAL MAMMARY; NEOADJUVANT CHEMOTHERAPY; ADJUVANT TRASTUZUMAB; RADIATION-THERAPY; MULTICENTER; RECURRENCE; SURVIVAL; EFFICACY; SAFETY
제목
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer
저자
Kim, Nalee; Kim, Ji-Yeon; Park, Won; Cho, Won Kyung; Kim, Tae Gyu; Im, Young-Hyuck; Ahn, Jin Seok; Lee, Jeong Eon; Nam, Seok Jin; Kim, Seok Won; Yu, Jonghan; Chae, Byung Joo; Lee, Sei Kyung; Ryu, Jai -Min; Park, Yeon Hee; Kim, Haeyoung
DOI
10.1016/j.breast.2023.103594
발행일
2023-12
유형
Article
저널명
Breast
권
72